← Back
Procter & Gamble
PG · listed on the New York Stock Exchange · worth $374.48 billion
$161.57
+0.61% on Oct 30
No insider bought Procter & Gamble stock in the last year. They sold it 30 times, $68.86 million in all. 14 members of Congress reported trading Procter & Gamble in the last year.
Red dot = an insider soldA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
2.3B shares
100% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, 14 insiders sold Procter & Gamble stock and none bought. None of the 30 sales is marked on its filing as planned in advance; all by company executives. The biggest seller was Jon R. Moeller, Exec. Chairman of the Board.
Planned sales
Form 144 notices filed for Procter & Gamble in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
Executive Moses Victor Javier Aguilar filed to sell 18,812 shares on 29 Oct; no sale reported yetNotice on SEC.gov
CEO de Azevedo Juliana Monteiro Santos filed to sell 5,370 shares on 26 Oct; no sale reported yetNotice on SEC.gov
CEO Paul Gama filed to sell 14,623 shares on 22 Oct; sold 4,331 by 23 OctNotice on SEC.gov
US Congress
Members of Congress who reported trading Procter & Gamble in the last year. They have up to 45 days to report, so the newest trades show up late.
MemberTradeAmountWhose accountTradedReported
All reports
Every insider trade and SEC report we hold for Procter & Gamble.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Oct 26SoldShailesh JejurikarOct 26 · Traded Oct 23 · Chairman, President and CEO35,000 @ $163.09$5.71M
Oct 26SoldBalaji PurushothamanOct 26 · Traded Oct 23 · Chief Human Resources Officer4,181 @ $160.71$671.9K
Aug 27SoldMoses Victor Javier AguilarAug 27 · Traded Aug 20 · Chf Rsch, Dev & Innov Officer3,053 @ $143.79$439K
49 more with Pro →Analysts, earnings and news
Analysts' price target
$163.43 average
23 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
4 of 4 quarters above
Q1 '26$1.59 a share+$0.03
Q4 '25$1.88 a share+$0.02
Q3 '25$1.99 a share+$0.09
Q2 '25$1.48 a share+$0.06